Jun Li, MD, PhD, MPH

Jun Li, MD, PhD, MPH, is an epidemiologist in the Division of Cancer Prevention and Control’s (DCPC’s) Epidemiology and Applied Research Branch. In July 2006, he joined CDC as an Epidemic Intelligence Service (EIS) officer in DCPC. His research interests focus on preventing and controlling prostate and childhood cancers. Dr. Li served as DCPC’s point of contact for a multi-state birth defect and childhood cancer linkage study. He also works with grantees to better understand barriers to colorectal cancer (CRC) screening and implement evidence-based interventions to promote CRC screening among Asian subpopulations. In addition, he leads research projects to monitor prostate cancer and childhood cancer incidence and mortality, as well as use of prostate cancer screening across the nation. Dr. Li also has strong interests in cancer genomics. He received CDC’s Public Health Genomics Fellowship Award in 2007.

Prior to coming to CDC, he worked as postdoctoral research associate in Emory University’s Department of Orthopedics, focusing on gene therapy for spinal degeneration. The International Society for the Study of Lumbar Spine (ISSLS) Research awarded him the ISSLS prize in 2004.

Dr. Li earned his MD from a seven-year program at Xi’an Medical University in 1998. He was trained jointly by Xi’an Jiaotong University and Emory University for his PhD. He received his MPH in epidemiology from the Rollins School of Public Health at Emory.

Dr. Li has published more than 50 peer-reviewed papers and government reports. The most recent articles that Dr. Li first-authored include—

• 2017 Prostate cancer screening decision-making in three states: 2013 Behavioral Risk Factor Surveillance System analysis.
• 2016 Racial and ethnic differences in health behaviors and preventive health services among prostate cancer survivors in the United States.
• 2015 Decrease in prostate cancer testing following the U.S. Preventive Services Task Force recommendations.
• 2015 Pre-screening discussions and prostate-specific antigen testing for prostate cancer screening.
• 2014 Testing for human immunodeficiency virus among cancer survivors under age 65 in the United States.
• 2014 Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990–2009.
• 2013 Shared decision making in prostate-specific antigen testing with men older than 70 years.
• 2012 Recent trends in prostate cancer incidence by age, cancer stage, and grade.
• 2012 Association between smoking status and free, total, and percent prostate-specific antigen.
• 2011 Recent trends in prostate cancer testing and incidence among men under age of 50.
• 2010 Use of the prostate-specific antigen test among men aged 75 years or older in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System.
• 2010 Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.
• 2010 Quality assessment of colonoscopy reporting: results from a cancer screening and treatment program.
• 2008 Cancer incidence among children and adolescents in the United States, 2001–2003.
• 2007 Trends in childhood cancer mortality—United States, 1990–2004.